HCA Healthcare shares fell -4.4% this afternoon to a price of $395.14. The stock is still trading within range of its average target price of $401.19, and over the last 52 weeks, it has recorded a 6.4% performance. Analysts have given the Large-Cap Medical Care Facility stock target prices ranging from $333.0 to $449.0 dollars per share, with an average rating of buy.
The stock has an average amount of shares sold short at 2.5%, and a short ratio of 2.7. The company's insiders own 30.81% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that an average number of institutional investors are invested in the stock, with 63.2% of HCA Healthcare's shares being owned by this investor type.
Institutions Invested in HCA Healthcare
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-06-30 | Vanguard Group Inc | 7% | 15,475,564 | $6,115,014,585 |
| 2025-06-30 | Blackrock Inc. | 6% | 12,950,880 | $5,117,410,912 |
| 2025-06-30 | Sanders Capital, LLC | 5% | 11,102,583 | $4,387,074,809 |
| 2025-06-30 | State Street Corporation | 3% | 7,956,663 | $3,143,995,934 |
| 2025-06-30 | Capital World Investors | 2% | 4,779,893 | $1,888,726,990 |
| 2025-06-30 | First Eagle Investment Management, LLC | 2% | 4,209,857 | $1,663,482,956 |
| 2025-06-30 | Wellington Management Group, LLP | 2% | 4,110,313 | $1,624,149,139 |
| 2025-06-30 | Geode Capital Management, LLC | 2% | 3,797,902 | $1,500,703,051 |
| 2025-06-30 | JPMORGAN CHASE & CO | 1% | 3,279,334 | $1,295,796,084 |
| 2025-06-30 | NORGES BANK | 1% | 3,008,113 | $1,188,625,814 |
Besides an analyst consensus of some upside potential, other market factors point to there being positive market sentiment on HCA Healthcare.
